Oncology Nurse Advisor1d
CD70-Directed CAR-T Therapy Shows Promise in T-Cell Lymphoma
Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...
BioSpace17d
Cutaneous Squamous Cell Carcinoma Market Size to Reach USD 14.0 Billion by 2035, Impelled by Technological Advancements in Treatment Modalities
The primary driver of this market expansion is the shift ... of 4.65% during 2024-2034. Cutaneous T-Cell Lymphoma Market: The 7 major Cutaneous T-cell-lymphoma market reached a value of US$ 428.2 ...
Everyday Health29d
Stage 4 Lymphoma
Hodgkin lymphoma (formerly known as Hodgkin disease), which involves an abnormal type of lymphocyte called Reed-Sternberg cells Non-Hodgkin lymphoma, which does not contain Reed-Sternberg cells ...